Get the Stockscreener App
1.96
7.55%
-0.16
After Hours:
2.05
0.09
+4.59%
Adc Therapeutics Sa Stock (ADCT) Forecast
The Adc Therapeutics Sa (ADCT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.8262, representing a +95.22% increase from the current price of $1.96. The highest analyst price target is $3.8181, and the lowest is $3.8344.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ADCT Price Target
Average 5.40
(+175.51% Upside)
Is Adc Therapeutics Sa (ADCT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 43.52 | Neutral |
| STOCH(9,6) | 11.93 | Buy |
| STOCHRSI(14) | 30.85 | Neutral |
| MACD(12,26) | -0.1517 | Sell |
| ADX(14) | 16.58 | Neutral |
| William %R | -90.53 | Buy |
| CCI(14) | -46.41 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.29
Sell
|
2.1495
Sell
|
| MA20 |
2.2665
Sell
|
2.2707
Sell
|
| MA50 |
2.618
Sell
|
2.521
Sell
|
| MA100 |
2.7894
Sell
|
2.7688
Sell
|
| MA200 |
3.3633
Sell
|
2.7569
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ADCT could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on ADCT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 43.52 indicates that ADCT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 11.93 indicates that ADCT is oversold. This indicates that ADCT price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 30.85 indicates that ADCT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.58 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -46.41 indicates that ADCT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ADCT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Adc Therapeutics Sa financial reports and earnings history, Adc Therapeutics Sa (ADCT) stock could reach $25.85 by 2030, $35.32 by 2040 and $99.65 by 2050. See the projected annual prices until 2050 of the Adc Therapeutics Sa stock below:
- Adc Therapeutics Sa (ADCT) is expected to reach an average price of $53.50 in 2035, with a high prediction of $55.39 and a low estimate of $53.56. This indicates an $2,630% rise from the last recorded price of $1.96.
- Adc Therapeutics Sa (ADCT) stock is projected to chart a bullish course in 2040, with an average price target of $33.83, representing an $1,626% surge from its current level. The forecast ranges from a conservative $34.67 to a sky-high $35.32.
- Our analysts predict Adc Therapeutics Sa (ADCT) to jump 3,120% by 2045, soaring from $63.41 to an average price of $63.11, potentially reaching $66.12. While $63.41 is the low estimate, the potential upside is significant.
- Adc Therapeutics Sa (ADCT) stock is expected to climb by 2050, reaching an average of $96.80, a $4,839% jump from its current level. However, a wide range of estimates exists, with high and low targets of $99.65 and $96.82, respectively, highlighting the market's uncertainty.
Adc Therapeutics Sa Stock (ADCT) Year by Year Forecast
Adc Therapeutics Sa Stock (ADCT) Price Forecast for 2025
Adc Therapeutics Sa Stock (ADCT) is expected to reach an average price of $5.40 in 2025, with a high prediction of $10.78 and a low estimate of $0.0237. This indicates an +175.51% rise from the last recorded price of $1.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $3.6844 | $3.8344 | $3.8181 | +87.98% |
| February, 2025 | $3.4306 | $3.5723 | $3.6279 | +75.03% |
| March, 2025 | $2.5568 | $2.8568 | $3.0547 | +30.45% |
| April, 2025 | $1.0872 | $2.0372 | $2.2509 | -44.53% |
| May, 2025 | $1.7566 | $0.1393 | $1.9266 | -10.38% |
| June, 2025 | $1.1903 | $0.9985 | $2.5625 | -39.27% |
| July, 2025 | $1.36 | $0.0237 | $2.28 | -30.61% |
| August, 2025 | $1.6489 | $1.136 | $2.1619 | -15.87% |
| September, 2025 | $10.93 | $2.21 | $10.78 | +457.88% |
| October, 2025 | $10.36 | $10.42 | $10.68 | +428.83% |
| November, 2025 | $9.5275 | $9.6075 | $9.6231 | +386.10% |
| December, 2025 | $9.1681 | $9.2137 | $9.2556 | +367.76% |
Adc Therapeutics Sa Stock (ADCT) Price Forecast for 2026
The predicted value for Adc Therapeutics Sa (ADCT) in 2026 is set at an average of $5.3415. Estimates vary from a peak of $9.4206 to a trough of $1.2624, indicating an +172.53% surge from the present price of $1.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $9.5906 | $9.1362 | $9.4206 | +389.32% |
| February, 2026 | $9.0531 | $9.0531 | $9.2587 | +361.89% |
| March, 2026 | $8.9056 | $8.9075 | $8.9057 | +354.37% |
| April, 2026 | $8.6162 | $8.6658 | $8.8668 | +339.60% |
| May, 2026 | $8.1687 | $8.3187 | $8.459 | +316.77% |
| June, 2026 | $7.6912 | $7.8329 | $8.0003 | +292.41% |
| July, 2026 | $6.3018 | $6.4818 | $7.2593 | +221.52% |
| August, 2026 | $4.8443 | $5.7943 | $5.7699 | +147.16% |
| September, 2026 | $2.2749 | $2.4049 | $3.9024 | +16.07% |
| October, 2026 | $2.7274 | $1.8712 | $1.7874 | +39.15% |
| November, 2026 | $1.6699 | $1.7499 | $1.3856 | -14.80% |
| December, 2026 | $8.51 | $1.2624 | $7.35 | +334.18% |
Adc Therapeutics Sa Stock (ADCT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Adc Therapeutics Sa (ADCT) is $12.87, with a high forecast of $17.27 and a low forecast of $8.4737. This indicates an +556.84% increase from the last price of $1.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $17.12 | $17.26 | $17.27 | +773.41% |
| February, 2027 | $16.53 | $16.59 | $16.58 | +743.24% |
| March, 2027 | $15.16 | $15.37 | $15.73 | +673.39% |
| April, 2027 | $14.83 | $15.04 | $14.84 | +656.49% |
| May, 2027 | $15.03 | $14.74 | $14.87 | +666.63% |
| June, 2027 | $14.18 | $14.18 | $14.64 | +623.31% |
| July, 2027 | $13.98 | $13.91 | $14.01 | +613.04% |
| August, 2027 | $13.32 | $13.37 | $13.74 | +579.81% |
| September, 2027 | $12.82 | $12.80 | $13.11 | +553.84% |
| October, 2027 | $11.50 | $11.76 | $12.37 | +486.94% |
| November, 2027 | $10.28 | $10.46 | $11.27 | +424.63% |
| December, 2027 | $7.9837 | $8.4737 | $9.6949 | +307.33% |
Adc Therapeutics Sa Stock (ADCT) Price Forecast for 2028
In 2028, Adc Therapeutics Sa (ADCT) is projected to reach an average price of $13.92, with a high projection of $23.77 and a low estimate of $4.0686. This indicates an +610.23% rise from the last price of $1.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.7524 | $5.8824 | $7.1158 | +193.49% |
| February, 2028 | $5.9811 | $5.2368 | $5.0411 | +205.16% |
| March, 2028 | $4.2021 | $4.7799 | $4.5833 | +114.39% |
| April, 2028 | $15.12 | $4.0686 | $13.96 | +671.43% |
| May, 2028 | $23.14 | $23.33 | $23.77 | +1,081% |
| June, 2028 | $22.09 | $22.49 | $22.79 | +1,027% |
| July, 2028 | $21.04 | $21.25 | $21.46 | +973.53% |
| August, 2028 | $20.16 | $20.34 | $20.67 | +928.70% |
| September, 2028 | $20.04 | $20.24 | $20.36 | +922.32% |
| October, 2028 | $19.33 | $19.33 | $19.76 | +886.35% |
| November, 2028 | $18.78 | $18.80 | $19.11 | +858.36% |
| December, 2028 | $17.78 | $17.95 | $18.32 | +807.08% |
Adc Therapeutics Sa Stock (ADCT) Price Forecast for 2029
The 2029 price forecast for Adc Therapeutics Sa Stock (ADCT) is $18.57 on average, with a high prediction of $30.27 and a low estimate of $6.8748. This represents an +847.59% increase from the previous price of $1.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $16.79 | $17.13 | $17.56 | +756.44% |
| February, 2029 | $15.57 | $15.65 | $16.49 | +694.64% |
| March, 2029 | $13.67 | $14.25 | $14.51 | +597.44% |
| April, 2029 | $11.68 | $12.17 | $13.23 | +496.17% |
| May, 2029 | $8.8561 | $9.2661 | $10.76 | +351.84% |
| June, 2029 | $8.2511 | $8.6024 | $8.3924 | +320.98% |
| July, 2029 | $7.1761 | $7.7861 | $7.5574 | +266.13% |
| August, 2029 | $30.53 | $6.8748 | $30.02 | +1,458% |
| September, 2029 | $29.47 | $29.66 | $30.27 | +1,404% |
| October, 2029 | $27.70 | $27.90 | $29.01 | +1,313% |
| November, 2029 | $26.61 | $26.69 | $27.32 | +1,258% |
| December, 2029 | $25.77 | $25.95 | $26.27 | +1,215% |
Adc Therapeutics Sa Stock (ADCT) Price Forecast for 2030
Adc Therapeutics Sa Stock (ADCT) is expected to reach an average price of $23.13 in 2030, with a high forecast of $36.57 and a low forecast of $9.6811. This signifies an +1,080% surge from the last price of $1.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $25.15 | $25.23 | $25.85 | +1,183% |
| February, 2030 | $24.30 | $24.35 | $24.65 | +1,140% |
| March, 2030 | $23.66 | $23.68 | $24.00 | +1,107% |
| April, 2030 | $22.43 | $22.60 | $23.14 | +1,044% |
| May, 2030 | $21.16 | $21.50 | $22.15 | +979.53% |
| June, 2030 | $19.72 | $19.80 | $20.81 | +906.31% |
| July, 2030 | $17.22 | $17.53 | $18.60 | +778.33% |
| August, 2030 | $14.63 | $15.31 | $17.01 | +646.25% |
| September, 2030 | $12.28 | $12.69 | $13.34 | +526.41% |
| October, 2030 | $11.22 | $11.64 | $11.76 | +472.41% |
| November, 2030 | $10.25 | $10.38 | $10.24 | +422.98% |
| December, 2030 | $37.08 | $9.6811 | $36.57 | +1,792% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):